Moreover, GRP78 expression was positively related to poor prognosis and served as a marker of response to preoperative chemotherapy in patients with various cancers, including breast cancer, pulmonary adenocarcinoma, myeloma, and pancreatic cancer [7,8,9,10]. This evidence concerns the gene HSPA5 and cancer.